Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amparo Ruiz

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Breast Cancer Research and Treatment|February 25, 2016
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-studyMiguel Martin, Jan C Brase, Amparo Ruiz, et al.
Breast Cancer Research and Treatment|December 29, 2009
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancerMiguel Martín, Alvaro Rodríguez-Lescure, Amparo Ruiz, et al.
The Lancet. Oncology|March 3, 2007
Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trialMiguel Martín, Amparo Ruiz, Monserrat Muñoz, et al.
Scientific Reports|December 29, 2019
Magnetic resonance microscopy and correlative histopathology of the infarcted heartItziar Perez-Terol, Cesar Rios-Navarro, Elena de Dios, et al.
The Oncologist|January 21, 2016
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast CancerEmilio Alba, Ana Lluch, Nuria Ribelles, et al.
Journal of the Academy of Nutrition and Dietetics|July 5, 2016
Evaluating the Applicability of Data-Driven Dietary Patterns to Independent Samples with a Focus on Measurement Tools for Pattern SimilarityAdela Castelló, Brian Buijsse, Miguel Martín, et al.
Plos One|May 16, 2015
Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control StudyAdela Castelló, Miguel Martín, Amparo Ruiz, et al.
Scientific Reports|March 9, 2019
Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM studyVirginia Lope, Miguel Martín, Adela Castelló, et al.
Plos One|October 7, 2017
Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective studyIván Márquez-Rodas, Marina Pollán, María José Escudero, et al.
Gynecologic Oncology|January 7, 2017
Physical activity and breast cancer risk by pathological subtypeVirginia Lope, Miguel Martín, Adela Castelló, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Breast Cancer Research and Treatment|February 25, 2016
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-studyMiguel Martin, Jan C Brase, Amparo Ruiz, et al.
Breast Cancer Research and Treatment|December 29, 2009
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancerMiguel Martín, Alvaro Rodríguez-Lescure, Amparo Ruiz, et al.
The Lancet. Oncology|March 3, 2007
Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trialMiguel Martín, Amparo Ruiz, Monserrat Muñoz, et al.
Scientific Reports|December 29, 2019
Magnetic resonance microscopy and correlative histopathology of the infarcted heartItziar Perez-Terol, Cesar Rios-Navarro, Elena de Dios, et al.
The Oncologist|January 21, 2016
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast CancerEmilio Alba, Ana Lluch, Nuria Ribelles, et al.
Journal of the Academy of Nutrition and Dietetics|July 5, 2016
Evaluating the Applicability of Data-Driven Dietary Patterns to Independent Samples with a Focus on Measurement Tools for Pattern SimilarityAdela Castelló, Brian Buijsse, Miguel Martín, et al.
Plos One|May 16, 2015
Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control StudyAdela Castelló, Miguel Martín, Amparo Ruiz, et al.
Scientific Reports|March 9, 2019
Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM studyVirginia Lope, Miguel Martín, Adela Castelló, et al.
Plos One|October 7, 2017
Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective studyIván Márquez-Rodas, Marina Pollán, María José Escudero, et al.
Gynecologic Oncology|January 7, 2017
Physical activity and breast cancer risk by pathological subtypeVirginia Lope, Miguel Martín, Adela Castelló, et al.
Pageof 18